AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2557685 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium phosphate remineralizing slurry (CPRS) for 1 hour
Number of subjects: 3
Study 2557685 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscous CPRS containing carboxymethyl cellulose (CMC) gel for 8 hours
Number of subjects: 3
Study 2557685 — intervention group
Group type: COMPARATOR
Intervention: Control group soaked in saliva-like (SL) solution
Number of subjects: 3
Study 1101719 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation
Number of subjects: 100
Study 1101719 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study 31055663 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar limited discectomy
Number of subjects: 278
Study 28328709 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fluence Q-switched 1,064-nm neodymium:yttrium-aluminum-garnet laser (QSNYL) weekly for 10 sessions on one cheek
Number of subjects: 22
Study 25922285 — intervention group
Group type: COMPARATOR
Intervention: Standard setting with three proximal humeral head screws alone (Group I)
Number of subjects: 14
Study 25922285 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental unlocked calcar screw (CS) (Group II)
Number of subjects: 14
Study 23934747 — intervention group
Group type: EXPERIMENTAL
Intervention: AIMS (Anesthesia Information Management System)
Number of subjects: 400
Study 23934747 — intervention group
Group type: COMPARATOR
Intervention: Handwritten records
Number of subjects: 400
Study 23934747 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive observation
Number of subjects: 400
Study 23934747 — intervention group
Group type: COMPARATOR
Intervention: Reduced observation
Number of subjects: 400
Study 21384650 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg droperidol intravenously before operation
Number of subjects: 200
Study 21384650 — intervention group
Group type: COMPARATOR
Intervention: Control group (no droperidol)
Number of subjects: 200
Study 19590447 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 170
Study 17257447 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 16378
Study 15538041 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) 20 mg
Number of subjects: 197
Study 15538041 — intervention group
Group type: EXPERIMENTAL
Intervention: Toremifene (TOR) 40 mg
Number of subjects: 197
Study 15538041 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from TAM to TOR
Number of subjects: 197
Study 15538041 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from TOR to TAM
Number of subjects: 197
Study 11053173 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife led debriefing
Number of subjects: 1041
Study 11053173 — intervention group
Group type: COMPARATOR
Intervention: Usual postpartum care
Number of subjects: 1041
Study 8971283 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg cisapride
Number of subjects: 15
Study 8971283 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg cisapride
Number of subjects: 15
Study 8971283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 1617510 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (15 g/day MaxEPA, 4.5 g eicosapentaenoic and docosahexaenoic acids)
Number of subjects: 125
Study 1617510 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 125
Study 6367719 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluosol-DA 20% (PFC emulsion)
Number of subjects: 13
Study 29390862 — intervention group
Group type: EXPERIMENTAL
Intervention: Process incentives (earned by attending primary care visits and/or receiving prescription medication refills)
Number of subjects: 1879
Study 29390862 — intervention group
Group type: EXPERIMENTAL
Intervention: Outcome incentives (earned by reducing systolic blood pressure or hemoglobin A1c levels)
Number of subjects: 1879
Study 29390862 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined process and outcome incentives
Number of subjects: 1879
Study 29390862 — intervention group
Group type: COMPARATOR
Intervention: Control (no incentives)
Number of subjects: 1879
Study 27149587 — intervention group
Group type: EXPERIMENTAL
Intervention: Swing resistance training
Number of subjects: 14
Study 27149587 — intervention group
Group type: COMPARATOR
Intervention: Swing assistance training
Number of subjects: 14
Study 25778507 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotavirus vaccine
Number of subjects: 0
Study 25778507 — intervention group
Group type: COMPARATOR
Intervention: Rotavirus diarrhea
Number of subjects: 0
Study 23880148 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation program with education and practical training along with home visits by a community health nurse
Number of subjects: 80
Study 23880148 — intervention group
Group type: COMPARATOR
Intervention: Routine cardiac rehabilitation program in the rehabilitation center (Control)
Number of subjects: 80
Study 23880148 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation program
Number of subjects: 80
Study 23880148 — intervention group
Group type: COMPARATOR
Intervention: Routine cardiac rehabilitation program (Control)
Number of subjects: 80
Study 20210495 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential touching procedure for object categorization
Number of subjects: 80
Study 20210495 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual analyses of categorization
Number of subjects: 80
Study 20210495 — intervention group
Group type: COMPARATOR
Intervention: Group analyses of categorization
Number of subjects: 80
Study 18438560 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable composite resin (Filtek Flow) applied on top of adhesive systems
Number of subjects: 0
Study 18438560 — intervention group
Group type: COMPARATOR
Intervention: No flowable composite resin applied
Number of subjects: 0
Study 18438560 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond with flowable composite
Number of subjects: 0
Study 18438560 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive systems tested: Scotchbond Multipurpose, Single Bond Adper Prompt, Clearfil SE Bond
Number of subjects: 0
Study 18603890 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone 4‐6 mg per day
Number of subjects: 0
Study 18603890 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol 10‐20 mg per day
Number of subjects: 0
Study 12580867 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke patients (developed post-stroke depression)
Number of subjects: 0
Study 12580867 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke patients (not developed post-stroke depression)
Number of subjects: 0
Study 12580867 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (normal subjects)
Number of subjects: 0
Study 10381297 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose garlic powder dragees
Number of subjects: 152
Study 8709585 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigator-observed flushing after alcohol challenge (0.75 ml/kg alcohol)
Number of subjects: 50
Study 8709585 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report of facial flushing
Number of subjects: 50
Study 8709585 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 50
Study 2058997 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat diet and intensive physical exercise (n = 18)
Number of subjects: 45
Study 2058997 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 27)
Number of subjects: 45
Study 6359913 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination ampicillin, amikacin, and clindamycin (Group I)
Number of subjects: 100
Study 6359913 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination doxycycline and penicillin (Group II)
Number of subjects: 100
Study 6359913 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbenicillin (Group III)
Number of subjects: 100
Study 3892220 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppression plus plasma exchange
Number of subjects: 17
Study 3892220 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppression alone
Number of subjects: 17
Study 30213005 — intervention group
Group type: COMPARATOR
Intervention: Center-based exercise training (ROT group)
Number of subjects: 0
Study 30213005 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitored home-based exercise training (ITG group)
Number of subjects: 0
Study 30213005 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ROT and ITG)
Number of subjects: 0
Study 27471201 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 726
Study 27471201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study 24625833 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamer-Irrigator-Aspirator (RIA)
Number of subjects: 133
Study 24625833 — intervention group
Group type: COMPARATOR
Intervention: Iliac Crest Bone Graft (ICBG)
Number of subjects: 133
Study 24625833 — intervention group
Group type: COMPARATOR
Intervention: Posterior ICBG
Number of subjects: 133
Study 24625833 — intervention group
Group type: COMPARATOR
Intervention: Anterior ICBG
Number of subjects: 133
Study 22782050 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fluoride dentifrice with tricalcium phosphate (5,000 ppm fluoride)
Number of subjects: 30
Study 22782050 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fluoride dentifrice without tricalcium phosphate (5,000 ppm fluoride)
Number of subjects: 30
Study 22782050 — intervention group
Group type: COMPARATOR
Intervention: Fluoride-free dentifrice
Number of subjects: 30
Study 20834083 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus cotrimoxazole
Number of subjects: 81
Study 20834083 — intervention group
Group type: COMPARATOR
Intervention: Artesunate plus chloroquine
Number of subjects: 81
Study 18070238 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy
Number of subjects: 0
Study 18070238 — intervention group
Group type: EXPERIMENTAL
Intervention: Social behaviour and network therapy
Number of subjects: 0
Study 15695996 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg) and Vitamin E (400 IU) supplementation
Number of subjects: 100
Study 15695996 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 12544986 — intervention group
Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated) 24 microg/kg/hr for 96 hours
Number of subjects: 1690
Study 12544986 — intervention group
Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated)
Number of subjects: 1690
Study 12544986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1690
Study 10824881 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitzmark capsule administration
Number of subjects: 21
Study 10824881 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma concentration of acetaminophen at 45 min after oral administration
Number of subjects: 21
Study 10824881 — intervention group
Group type: EXPERIMENTAL
Intervention: CV(R‐R) measurement
Number of subjects: 21
Study 8637787 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week benzathine penicillin G (BPG) program
Number of subjects: 249
Study 8637787 — intervention group
Group type: COMPARATOR
Intervention: 4-week benzathine penicillin G (BPG) program
Number of subjects: 249
Study 1386223 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone 1.0 mg kg‐1 administered approximately 10 min before weaning from CPB
Number of subjects: 80
Study 1386223 — intervention group
Group type: COMPARATOR
Intervention: Control group (no enoximone)
Number of subjects: 80
Study 6366823 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 60
Study 6366823 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentobarbitone (100 mg)
Number of subjects: 60
Study 6366823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31901759 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital CBT-I intervention (6 weeks)
Number of subjects: 199
Study 31901759 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving puzzles (6 weeks)
Number of subjects: 199
Study 30850442 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 609
Study 30850442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 609
Study 27909894 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT + SRP
Number of subjects: 45
Study 27909894 — intervention group
Group type: COMPARATOR
Intervention: MC + SRP
Number of subjects: 45
Study 27909894 — intervention group
Group type: COMPARATOR
Intervention: SRP-alone
Number of subjects: 45
Study 26162573 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical vapocoolant spray
Number of subjects: 50
Study 26162573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 23538455 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training (two 30-minute sessions per week for seven weeks)
Number of subjects: 0
Study 23538455 — intervention group
Group type: COMPARATOR
Intervention: Over ground gait training (two 30-minute sessions per week for seven weeks)
Number of subjects: 0
Study 21570534 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 4731
Study 21570534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4731
Study 19670088 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (3 fractions in 8 days)
Number of subjects: 70
Study 19670088 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy followed by hyperthermia (aimed for 43°C for 60 min)
Number of subjects: 70
Study 19670088 — intervention group
Group type: COMPARATOR
Intervention: Radiation dose of 24 Gy
Number of subjects: 70
Study 19670088 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation dose of 27 Gy
Number of subjects: 70
Study 19670088 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermia
Number of subjects: 70
Study 19670088 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor size
Number of subjects: 70
Study 19670088 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation dose
Number of subjects: 70
Study 19670088 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rate
Number of subjects: 70
Study 16945896 — intervention group
Group type: EXPERIMENTAL
Intervention: True artificial interferences
Number of subjects: 0
Study 16945896 — intervention group
Group type: COMPARATOR
Intervention: Type of intervention not specified
Number of subjects: 0
Study 15645008 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept (intramuscular or intravenous administration)
Number of subjects: 1060
Study 15645008 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept (second course of therapy)
Number of subjects: 1060
Study 15645008 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept
Number of subjects: 1060
Study 11887654 — intervention group
Group type: EXPERIMENTAL
Intervention: Functionally loaded implants (group 1)
Number of subjects: 20
Study 11887654 — intervention group
Group type: COMPARATOR
Intervention: Unloaded one-stage control implants (group 2)
Number of subjects: 20
Study 11887654 — intervention group
Group type: COMPARATOR
Intervention: Unloaded submerged technique control implants (group 3)
Number of subjects: 20
Study 9773720 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-starch meals (43% carbohydrate, 22% protein, 34% fat)
Number of subjects: 0
Study 9773720 — intervention group
Group type: COMPARATOR
Intervention: High-starch meals (55% carbohydrate, 15% protein, 30% fat)
Number of subjects: 0
Study 9773720 — intervention group
Group type: COMPARATOR
Intervention: Typical American meals (40% carbohydrate, 20% protein, 40% fat)
Number of subjects: 0
Study 9773720 — intervention group
Group type: COMPARATOR
Intervention: All three test diets
Number of subjects: 0
Study 7906578 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg dimethindene
Number of subjects: 12
Study 7906578 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg dimethindene
Number of subjects: 12
Study 7906578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3276336 — intervention group
Group type: EXPERIMENTAL
Intervention: Nystatin (1 ml, 100,000 units/ml) administered every 8 hours until 1 week after extubation
Number of subjects: 67
Study 3276336 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nystatin)
Number of subjects: 67
Study 30084706 — intervention group
Group type: EXPERIMENTAL
Intervention: AOT (Action Observation Training)
Number of subjects: 41
Study 30084706 — intervention group
Group type: COMPARATOR
Intervention: Control training (watching landscapes videos and execution)
Number of subjects: 41
Study 28807041 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Activity Monitor (EAM), Jawbone UP24 for 12 weeks
Number of subjects: 40
Study 28807041 — intervention group
Group type: COMPARATOR
Intervention: Pedometer for 12 weeks
Number of subjects: 40
Study 28807041 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group feedback from participants
Number of subjects: 40
Study 28807041 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall study reception
Number of subjects: 40
Study 25547219 — intervention group
Group type: EXPERIMENTAL
Intervention: YM155 plus docetaxel
Number of subjects: 101
Study 25547219 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 101
Study 23757437 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 375
Study 23757437 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 375
Study 22232848 — intervention group
Group type: COMPARATOR
Intervention: Tablets containing soy isoflavones 60 mg (genistin 30 mg + daidzin 30 mg) + calcium and vitamin D3
Number of subjects: 12
Study 22232848 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablets containing soy isoflavones 60 mg (genistin 30 mg + daidzin 30 mg) + calcium and vitamin D3 + 500 million vital spores of Lactobacillus sporogenes
Number of subjects: 12
Study 19523772 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD)
Number of subjects: 18
Study 19523772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 16237394 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5 mg)
Number of subjects: 0
Study 16237394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15884482 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to preferred music while out of restraining devices
Number of subjects: 30
Study 15884482 — intervention group
Group type: COMPARATOR
Intervention: No music while out of restraining devices
Number of subjects: 30
Study 15884482 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to preferred music while in restraining devices
Number of subjects: 30
Study 11076169 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM)
Number of subjects: 0
Study 11076169 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumer Reports study
Number of subjects: 0
Study 11076169 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirically Supported Treatments
Number of subjects: 0
Study 9348569 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT plus leucovorin
Number of subjects: 312
Study 9348569 — intervention group
Group type: COMPARATOR
Intervention: 5-FU plus leucovorin
Number of subjects: 312
Study 8328783 — intervention group
Group type: EXPERIMENTAL
Intervention: novobiocin plus rifampin
Number of subjects: 94
Study 8328783 — intervention group
Group type: COMPARATOR
Intervention: T/S plus rifampin
Number of subjects: 94
Study 3828866 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive professional development workshop
Number of subjects: 0
Study 3828866 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 29706691 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-mobilization group (SMG) performed upper thoracic self-mobilization using a Kaltenborn wedge
Number of subjects: 27
Study 29706691 — intervention group
Group type: COMPARATOR
Intervention: Self-stretching group (SSG) performed self-stretching exercises
Number of subjects: 27
Study 27161493 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and strength training program (24 weeks)
Number of subjects: 20
Study 27161493 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 24903556 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic bicyclol (75 mg, oral, daily)
Number of subjects: 306
Study 24903556 — intervention group
Group type: COMPARATOR
Intervention: Control (chemotherapy alone)
Number of subjects: 306
Study 22793958 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyelet wiring
Number of subjects: 0
Study 22793958 — intervention group
Group type: COMPARATOR
Intervention: Direct interdental wiring
Number of subjects: 0
Study 20685497 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal-bolus therapy (BBT) with insulin glargine once daily plus mealtime insulin lispro TID
Number of subjects: 2091
Study 20685497 — intervention group
Group type: COMPARATOR
Intervention: LM75/25 (75% insulin lispro protamine suspension and 25% insulin lispro injection) BID
Number of subjects: 2091
Study 20685497 — intervention group
Group type: COMPARATOR
Intervention: LM50/50 (50% insulin lispro protamine suspension and 50% insulin lispro injection) TID
Number of subjects: 2091
Study 18024231 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (supervised aerobic exercise for 4 months, 16 kcal kg(‐1) week(‐1), 60‐80% VO(2) max)
Number of subjects: 170
Study 17033111 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin with clarithromycin and proton pump inhibitor (PPI)
Number of subjects: 641
Study 17033111 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline, tinidazole, bismuth and PPI
Number of subjects: 641
Study 17033111 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin with clarithromycin and PPI supplemented with Lacidofil
Number of subjects: 641
Study 17033111 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 641
Study 12812378 — intervention group
Group type: EXPERIMENTAL
Intervention: Venoruton (HR)
Number of subjects: 80
Study 12812378 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80